Home
Scholarly Works
The Impact of Itraconazole, a Strong CYP3A4...
Journal article

The Impact of Itraconazole, a Strong CYP3A4 Inhibitor, on the Pharmacokinetics and Safety of Camlipixant in Healthy Participants

Authors

Peters A; Satia I; Chauret N; Gahir S; Garceau D; Julien R; Bailes Z; Zamacona M

Journal

The Journal of Allergy and Clinical Immunology, Vol. 155, No. 2,

Publisher

Elsevier

Publication Date

February 1, 2025

DOI

10.1016/j.jaci.2024.12.711

ISSN

0091-6749

Contact the Experts team